Inmune Bio (0Y2) Ownership - Who Owns Inmune Bio?
Inmune Bio (0Y2) Ownership Overview
- 10.81% Insiders
- 3.42% Mutual Funds
- 0.82% Other Institutional Investors
- 2.75% ETFs
- 82.19% Public Companies and Individual Investors
The ownership structure of Inmune Bio (DE:0Y2) stock is a mix of institutional, retail, and individual investors. Approximately 7.00% of the company’s stock is owned by Institutional Investors, 10.81% is owned by Insiders, and 82.19% is owned by Public Companies and Individual Investors.
The ownership structure of Inmune Bio (DE:0Y2) stock is a mix of institutional, retail, and individual investors. Approximately 7.00% of the company’s stock is owned by Institutional Investors, 10.81% is owned by Insiders, and 82.19% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Mark William Lowdell | 1,518,017 | Insider | 5.47% | 2,358,998 |
| David Moss | 1,294,883 | Insider | 4.67% | 2,012,248 |
| Vanguard | 686,263 | Institution | 2.47% | 1,066,453 |
| Vanguard Index Funds | 686,263 | Institution | 2.47% | 1,066,453 |
| BlackRock, Inc. | 311,613 | Institution | 1.12% | 484,247 |
| Fidelity Concord Street Trust | 238,061 | Institution | 0.86% | 369,947 |
| Scott Juda | 86,404 | Insider | 0.31% | 134,272 |
| Timothy J Schroeder | 82,187 | Insider | 0.30% | 127,719 |
| Ishares | 74,072 | Institution | 0.27% | 115,108 |
| Vanguard Valley Forge Funds | 20,161 | Institution | 0.07% | 31,330 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 686,263 | Institution | 2.47% | 1,066,453 |
| Fidelity Concord Street Trust | 238,061 | Institution | 0.86% | 369,947 |
| Vanguard Valley Forge Funds | 20,161 | Institution | 0.07% | 31,330 |
| Bridge Builder Trust | 2,925 | Institution | 0.01% | 4,545 |
| Victory Portfolios Iii | 1,306 | Institution | <0.01% | 2,030 |
| Morgan Stanley Pathway Funds | 904 | Institution | <0.01% | 1,405 |
| Profunds | 192 | Institution | <0.01% | 298 |
FAQ
Who Owns Inmune Bio (DE:0Y2)?
According to the latest TipRanks data, approximately 7.00% of the company's stock is held by institutional investors, 10.81% is held by insiders, and 82.19% is held by public companies and individual investors.
What percentage of Inmune Bio (DE:0Y2) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.00% of Inmune Bio (DE:0Y2) stock is held by institutional investors: 3.42% by mutual funds, 2.75% by ETFs and 0.82% by other institutional investors.
What percentage of Inmune Bio (DE:0Y2) stock is held by retail investors?
According to the latest TipRanks data, approximately 82.19% of Inmune Bio (DE:0Y2) stock is held by public companies and individual investors.
Who owns the most shares of Inmune Bio (DE:0Y2)?
Mark William Lowdell owns the most shares of Inmune Bio (DE:0Y2).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
